Incredible Prices for Cancer Drugs

An unusually bold stand by doctors at the Memorial Sloan-Kettering Cancer Center in New York has forced a big drug company to reduce the cost of an overpriced drug for treating colorectal cancer that was no better than a cheaper competitor and did almost nothing to extend a patient’s life. It is a heartening sign that alert and aggressive physicians can potentially play a major role in helping to reduce the escalating costs of health care for treatments of marginal value.

To continue reading, click here.

Print Print  

One comment to “Incredible Prices for Cancer Drugs”

  1. H. (Bart) Vincelette

    Some of the most deplorable & dishonest actions by the pharmaceutical industry took place with the advent of anti-HIV drugs. In many instances, when recovering research costs were claimed as a reason for the high prices; it came to light that the research had actually been done in US Army laboratories. With a drug called AZT, which was an older & largely inefficient anti-cancer drug which had been shelved; when it was found to be effective when used with other anti-HIV drugs; the cost quadrupled.

Leave a comment